Category: by country

Second retraction for researcher who faked 70+ experiments

Journal of Biological ChemistryTwo researchers found to have faked data by the U.S. Office of Research Integrity (ORI) have lost a paper that they co-authored.

According to the ORI report issued on May 25, Ricky Malhotra, one of the researchers in question, admitted to fabricating 74 experiments, and falsifying well over 100 Western blots while at the Universities of Michigan (UM) and Chicago (UC). One week later, the ORI issued additional findings about Karen D’Souza, a colleague of Malhotra’s at the UC, concluding that she had also falsified some data.

Both researchers agreed to the retraction of a 2010 paper published in The Journal of Biological Chemistry (JBC), the reports note.

Here’s the retraction notice, issued on July 1: Continue reading Second retraction for researcher who faked 70+ experiments

Is the bulk of fMRI data questionable?

Anders Eklund
Anders Eklund, via Linköping University

Last week, a study brought into question years of research conducted using the neuroimaging technique functional magnetic resonance imaging (fMRI). The new paper, published in PNAS, particularly raised eyebrows for suggesting that the rates of false positives in studies using fMRI could be up to 70%, which may affect many of the approximately 40,000 studies in academic literature that have so far used the technique. We spoke to the Anders Eklund, from Linköping University in Sweden, who was the first author of the study. Continue reading Is the bulk of fMRI data questionable?

A prominent psychiatry researcher is dismissed. What’s happening to his papers?

neumeister
Alexander Neumeister. Source: Yale School of Medicine

After a prominent researcher was dismissed due to multiple instances of misconduct in his studies, how are journals responding?

When an investigation by the U.S. Food and Drug Administration (FDA) found multiple issues with the work of psychiatry researcher Alexander Neumeister, New York University (NYU) Langone Medical Center shut down eight of his studies. (Disclosure: The author of this post is an NYU journalism student, but has no relationship with the medical school.) The agency concluded the studies, which involved using experimental drugs to relieve symptoms of post-traumatic stress disorder (PTSD), were tainted by lax oversight, falsified records, and inaccurate case histories, according to the New York Times. (Neuroskeptic also recently analyzed the case.)

We reached out to the journals that have published Neumeister’s papers, to ask if these recent events have caused them to take a second look at his work. Several have responded, with some noting they plan to investigate, or will do so if asked by the institution. But many believe there is little cause for concern. Continue reading A prominent psychiatry researcher is dismissed. What’s happening to his papers?

Should a paper be retracted if an author omits a conflict of interest?

s-cover-yvs1606A JAMA journal has quickly issued a correction for a 2016 paper after the author failed to mention several relevant conflicts of interest. Normally, we’d see this as a run-of-the-mill correction notice, but since we reported last week that a journal retracted a paper for omitting pharma funding, we got to wondering: Is failure to disclose a conflict of interest a retractable offense?

Guidelines from the Committee on Publication Ethics (COPE) do say that retractions are used for “failure to disclose a major competing interest likely to influence interpretations or recommendations.” But most of the time when we see corrections to the literature for such omissions, they’re corrections, not retractions.

On Friday, JAMA Ophthalmology issued a correction notice for an invited commentary published in April, which addressed two papers in the journal about melanoma of the eye (uveal melanoma). However, the original commentary failed to note that author Arun D. Singh at the Cleveland Clinic had some relevant conflicts to mention, as the notice explains: Continue reading Should a paper be retracted if an author omits a conflict of interest?

Vast majority of Americans want to criminalize data fraud, says new study

court caseAs Retraction Watch readers know, criminal sanctions for research fraud are extremely rare. There have been just a handful of cases — Dong-Pyou Han, Eric Poehlman, and Scott Reuben, to name several — that have led to prison sentences.

According to a new study, however, the rarity of such cases is out of sync with with the wishes of the U.S. population:
Continue reading Vast majority of Americans want to criminalize data fraud, says new study

Authors retract study that found pollution near fracking sites

Environmental Science and TechnologyThe authors of two environmental papers, including one about the effects of fracking on human health, have retracted them after discovering crucial mistakes.

One of the studies reported an increased level of air pollution near gas extraction sites, and the other suggested that 2010’s Deepwater Horizon oil spill in the Gulf of Mexico contributed to air contamination.

According to the corresponding author of both papers, Kim Anderson at Oregon State University, the journal plans to publish new versions of both papers in the next few days. In the case of the fracking paper, the conclusions have been reversed — the original paper stated pollution levels exceeded limits set by the U.S. Environmental Protection Agency (EPA) for lifetime cancer risk, but the corrected data set the risks below EPA levels.

The fracking paper received some media attention when it was released, as it tapped into long-standing concerns about the environmental dangers of hydraulic fracturing (fracking), which extracts natural gas from the earth. A press release that accompanied the paper quoted Anderson as warning: Continue reading Authors retract study that found pollution near fracking sites

Authors who lost paper linking fecal transplants to obesity have another retracted

International Journal of ObesityAn obesity journal has retracted a study by authors who previously lost another paper that suggested a link between the fecal microbiome and obesity.

We first came across on the now-retracted paper in the International Journal of Obesity (IJO) in April when we reported on the authors’ other retraction in Diabetes. The 2014 paper had a corrigendum, published the same year, and also for image-related issues. Since then, however, the journal has pulled the IJO paper and its associated corrigendum at the request of the French National Institute of Agronomic Research (INRA) in Paris. Continue reading Authors who lost paper linking fecal transplants to obesity have another retracted

PLOS ONE pulls malaria study for “inappropriate manipulation” of figures

PLOS OnePLOS ONE has retracted a malaria paper after an institutional investigation found evidence the authors had manipulated multiple figures.

According to the notice, the authors’ institution — the International Centre for Genetic Engineering and Biotechnology (ICGEB) in New Delhi, India — recommended the journal retract the paper.

Here’s the retraction notice, issued by PLOS ONE on June 30: Continue reading PLOS ONE pulls malaria study for “inappropriate manipulation” of figures

Five more retractions for biologist with funding ban brings total to six

Journal of Cell ScienceAn erstwhile cell biologist has retracted five papers published in the Journal of Cell Science (JCS), all of which had been flagged in a recent investigation by the U.S. Office of Research Integrity (ORI).

The investigation found John Pastorino, previously a cell biologist at Rowan University in New Jersey, guilty of doctoring more than 40 images, resulting in a five-year funding ban.

The probe identified eight papers co-authored by Pastorino, six of which had already received expressions of concern (EOC) — including all of the newly retracted JCS papers. Nataly Shulga is a co-author on all eight papers.

Last week, we reported on the first of the expected retractions of the flagged papers in the Journal of Biological Chemistry.

Here are the retraction notices, which are the same for all five JCS papers: Continue reading Five more retractions for biologist with funding ban brings total to six

Crow’s feet filler study omitted pharma funding, gets retracted

JKMSA paper on a filler for eye wrinkles did not disclose that it was funded by a pharmaceutical company that produces the cosmetic.

The paper explicitly noted that the authors do not have any financial conflicts of interest, and that a government program supported the study. According to the journal, a reader alerted them to the conflict of interest.

The cooperate tie wasn’t a secret, though — one of the authors was listed as affiliated with the  company, Pharma Research Products, based in Korea.

Here’s the retraction notice for “A Phase III, Randomized, Double-Blind, Matched-Pairs, Active-Controlled Clinical Trial and Preclinical Animal Study to Compare the Durability, Efficacy and Safety between Polynucleotide Filler and Hyaluronic Acid Filler in the Correction of Crow’s Feet: A New Concept of Regenerative Filler:”

Continue reading Crow’s feet filler study omitted pharma funding, gets retracted